EBV-Specific Anti-PD1 TCR-T Cells in the Treatment of EBV-Positive NHSCC
Condition: Head and Neck Squamous Cell Carcinoma Intervention: Drug: HPV E6-specific TCR-T cell with anti-PD1 auto-secreted element Sponsors: Xinqiao Hospital of Chongqing; TCRCure Biopharma Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials